| Literature DB >> 22226127 |
Alphonce B Chandika1, Anthony M Gakwaya, Elsie Kiguli-Malwadde, Phillipo L Chalya.
Abstract
BACKGROUND: Despite breast abscess becoming less common in developed countries, it has remained one of the leading causes of morbidity in women in developing countries. A randomized controlled trial was conducted at Mulago hospital complex in Kampala Uganda to establish whether ultrasound guided needle aspiration is a feasible alternative treatment option for breast abscesses.Entities:
Year: 2012 PMID: 22226127 PMCID: PMC3284878 DOI: 10.1186/1756-0500-5-12
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Figure 1A sonogram of a 22 yrs old female showing a right breast abscess. Note the oval shape of the abscess measuring 2.64 cm by 1.54 cm before aspiration under U.S.S guidance.
Figure 2U.S.S guided needle aspiration of the Right breast abscess of the above patient. Note the needle in the breast abscess cavity during the aspiration process (see the arrows).
Incision and drainage group had a recurrence rate of 3.1% (1/32) during the follow up period. 5 (7.7%) women of the 65 were lost to follow up, 4 patients were from the Ultrasound guided aspiration group and 1 patient from Incision and drainage group. Of the 4 patients in the aspiration group, 2 missed the 2nd visit and the other 2 patients missed the 3rd visit. The patient in the Incision and drainage group lost to follow up in the 3rd visit.
Figure 3Right breast after U.S.S guided needle Aspiration of the Abscess of the above patient. Note the disappearance of the abscess cavity leaving behind inflamed tissues as indicated by arrows.
Healing rates per group
| Study group | A | B | Odds ratio | 95%CI | P-value |
|---|---|---|---|---|---|
| 3% (1) | 9.4% (3) | 0.30 | 0.03-3.07 | 0.29 | |
| 29% (9) | 21.9% (7) | 1.46 | 0.47-4.58 | 0.51 | |
| 65.5% (19) | 58.1% (18) | 1.37 | 0.48-3.91 | 0.55 | |
Mean Healing time of the two study arms at different variables
| Variable | Mean healing time in weeks | Mean Difference | 95%CI | P-Value | |
|---|---|---|---|---|---|
| US Aspiration | I&D | ||||
| ≤ 20 | 27.5 | 30.0 | -2.46 | -6.2-1.3 | 0.19 |
| > 20 | 21.5 | 19.9 | 1.61 | -4.8-8.1 | 0.61 |
| ≤ 7 days | 20.6 | 22.0 | -1.42 | -11.8-8.9 | 0.77 |
| > 7 days | 28.7 | 24.0 | 4.70 | -0.7-10.2 | 0.09 |
| Yes | 26.1 | 25.8 | 0.25 | -4.9-5.3 | 0.92 |
| No | 22.5 | 15.8 | 6.70 | -2.5-15.9 | 0.15 |
| Primiparous | 26.0 | 26.4 | -0.45 | -7.1-6.2 | 0.88 |
| Multiparous | 21.3 | 21.6 | -0.35 | -8.1-7.4 | 0.93 |
| Nulliparous | 24.7 | 30.0 | -5.33 | -28.3-17.6 | 0.58 |
| Yes | 26.8 | 26.0 | 0.80 | -8.4-9.9 | 0.83 |
| No | 23.7 | 22.9 | 0.80 | -4.6-6.2 | 0.62 |
| Right | 23.3 | 24.1 | -0.73 | -7.8-6.3 | 0.83 |
| Left | 24.9 | 23.3 | 1.55 | -4.9-7.9 | 0.62 |
| LUQ 5 | 23.6 | 20.3 | 3.26 | -3.3-9.9 | 0.32 |
| MUQ 6 | 18.0 | 27.3 | -9.33 | -19.9-1.3 | 0.08 |
| LLQ 7 | 24.7 | 30.0 | -5.33 | -51.2-40 | 0.67 |
| MLQ 8 | 25.7 | 31.0 | -4.0 | -49.2-39 | 0.62 |
| ≤ 3 cm | 15.3 | 13.5 | 1.74 | -5.0-8.5 | 0.59 |
| > 3 cm | 27.1 | 30.0 | -2.90 | -5.93-0.11 | 0.06 |
| Oval | 22.0 | 30.0 | -8.0 | -18-3.0 | 0.11 |
| Irregular | 24.8 | 23.1 | -3.7 | -3.7-71 | 0.52 |
| Multiloculated | 24.6 | 14.0 | 10.7 | -35.2-56 | 0.42 |
| Subareolar | 17.5 | 25.4 | -7.8 | -20.2-4.5 | 0.18 |
| Periphery | 26.8 | 23.1 | 3.7 | -1.2-8.6 | 0.14 |
| Indeterminate | 22.0 | 30.0 | -8.0 | -184-168 | 0.67 |
Descriptive analysis
| Study Arm | Mean duration of survival (95% CI) | Median duration of survival (95% CI) |
|---|---|---|
| A | 24.24 (21.27-27.22) | 30.00 |
| B | 24.16 (21.06-27.27) | 30.00 (27.74-32.26) |
Figure 4Survival Function.
Figure 5Hazard Function.
Cost-Effectiveness analysis
| Category | Intervention | |
|---|---|---|
| Admission | 620000 | |
| Professional fee | 2900000 | 3100000 |
| Preoperative fee | 620000 | |
| Surgery fee | 6100000 | |
| Anesthetic fee | 3200000 | |
| Amenities | 580000 | 620000 |
| Sundries | 290000 | 310000 |
| Lodging | 930000 | |
| Intervention U.S.S | 870000 | |
| Cannula (FG 16) | 43500 | |
| Syringe 20cc | 29000 | |
| Drugs | 246500 | 259600 |
| Dr. in charge care fee | 290000 | 310000 |
| Health care fee | 290000 | 310000 |
| Wound dressing cost | 489500 | |
| Total | 5539000 | 16869100 |
| Number of patients | 29 | 31 |
| Cost-effectiveness ratio | 191000 | 544164.5 |